4574: Taiko Pharmaceutical Co.,Ltd. - Summary | Jitta

Taiko Pharmaceutical Co.,Ltd.

TYO:4574

Price
¥253.00
Loss Chance
50.9%
3.54JITTA SCORE
715.31%Over Jitta Line
Jitta Ranking
90 / 180
2,127 / 3,501
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (40)
Recent Business Performance (54)
Financial Strength (60)
Return to Shareholders (7)
Competitive Advantage (43)
Jitta Signs
Debt LevelLow Long Term Debt
Revenue and EarningEarning loss detected in 2023
Operating MarginDeclined
Recent Business PerformanceEarning decline 37.54% in the last year
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
3.54
715.31%
4.45
190.04%
Health Care Supplies
3.54
16.33%
4.13
158.40%
6.37
327.08%
COMPANY DESCRIPTION
Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products. It exports its products. The company was incorporated in 1946 and is headquartered in Osaka, Japan.